However, during pregnancy and puberty, the progression to malignancy and the number and size of neurofibromas may increase in women with NF1 [21], and the greater attention placed on the health of women during pregnancy or childbearing could be reflected in a greater tendency for NF1 to be reported on the death certificates of young women. This evidence concerns the gene NF1 and neurofibroma.